HALO vs LKQ · P/E 15, rev $857.7M vs P/E 14, rev $6.88B
Halozyme Therapeutics Inc (HALO) versus LKQ Corporation (LKQ) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
LKQ Corporation (LKQ) is a auto parts company listed on US.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported LKQ revenue for 2026-06-30 was $6.88B. Net income was $215.0M. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
Not investment advice. Open the HALO and LKQ stock pages for the full models.
Not investment advice.